RVTY – Revvity Inc
RVTY — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
7.36
Margin Of Safety %
39
Put/Call OI Ratio
0.23
EPS Next Q Diff
-0.4
EPS Last/This Y
3.34
EPS This/Next Y
0.59
Price
85.6
Target Price
117.88
Analyst Recom
2.32
Performance Q
-17.28
Upside
-46.3%
Beta
1.14
Ticker: RVTY
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | RVTY | 92.1 | 0.30 | 0.11 | 1979 |
| 2026-03-10 | RVTY | 90.31 | 0.30 | 0.05 | 1979 |
| 2026-03-11 | RVTY | 89.6 | 0.23 | 0.20 | 2129 |
| 2026-03-12 | RVTY | 84.7 | 0.23 | 463.00 | 2135 |
| 2026-03-13 | RVTY | 84.76 | 0.23 | 51.89 | 2135 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-13 | RVTY | 96.00 | 0.9 | 308.9 | 5.41 |
| 2026-02-17 | RVTY | 95.02 | 0.9 | 300.7 | 5.41 |
| 2026-02-18 | RVTY | 97.72 | 0.9 | 321.8 | 5.41 |
| 2026-02-19 | RVTY | 99.88 | 0.9 | 318.4 | 5.41 |
| 2026-02-20 | RVTY | 100.35 | 0.9 | - | 5.41 |
| 2026-02-23 | RVTY | 97.13 | 0.9 | - | 5.41 |
| 2026-02-24 | RVTY | 97.68 | 0.9 | - | 5.41 |
| 2026-02-25 | RVTY | 97.52 | 0.9 | - | 5.41 |
| 2026-02-26 | RVTY | 99.01 | 0.9 | 416.3 | 5.41 |
| 2026-02-27 | RVTY | 98.36 | 0.9 | 412.1 | 5.41 |
| 2026-03-02 | RVTY | 95.55 | 0.9 | 293.3 | 5.41 |
| 2026-03-03 | RVTY | 95.96 | 0.9 | 310.8 | 5.41 |
| 2026-03-04 | RVTY | 98.49 | 0.9 | 323.1 | 5.41 |
| 2026-03-05 | RVTY | 96.58 | 0.9 | 298.1 | 5.41 |
| 2026-03-06 | RVTY | 91.38 | 0.9 | 279.3 | 5.41 |
| 2026-03-09 | RVTY | 92.09 | 0.9 | 313.1 | 5.41 |
| 2026-03-10 | RVTY | 90.28 | 0.9 | 298.0 | 5.41 |
| 2026-03-11 | RVTY | 89.64 | 0.9 | 304.8 | 5.41 |
| 2026-03-12 | RVTY | 84.70 | 0.9 | 279.2 | 5.41 |
| 2026-03-13 | RVTY | 85.60 | 0.9 | 313.9 | 5.41 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-06 | RVTY | -8.29 | -2.17 | 7.15 |
| 2026-03-09 | RVTY | -8.29 | -2.27 | 7.15 |
| 2026-03-10 | RVTY | -8.29 | -2.27 | 7.15 |
| 2026-03-11 | RVTY | -8.29 | -2.27 | 7.36 |
| 2026-03-12 | RVTY | -8.29 | -2.27 | 7.36 |
| 2026-03-13 | RVTY | -8.29 | -2.27 | 7.36 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.7
Avg. EPS Est. Current Quarter
1.02
Avg. EPS Est. Next Quarter
1.3
Insider Transactions
-8.29
Institutional Transactions
-2.27
Beta
1.14
Average Sales Estimate Current Quarter
704
Average Sales Estimate Next Quarter
746
Fair Value
119.32
Quality Score
70
Growth Score
69
Sentiment Score
3
Actual DrawDown %
57.9
Max Drawdown 5-Year %
-59
Target Price
117.88
P/E
40.96
Forward P/E
14.32
PEG
1.6
P/S
3.35
P/B
1.33
P/Free Cash Flow
18.89
EPS
2.09
Average EPS Est. Cur. Y
5.41
EPS Next Y. (Est.)
6
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
8.47
Relative Volume
1.04
Return on Equity vs Sector %
-24.5
Return on Equity vs Industry %
-7.6
EPS 1 7Days Diff
EPS 1 30Days Diff
0.09
EBIT Estimation
313.9
Revvity, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 11000
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
RVTY
Latest News
—
Caricamento notizie per RVTY…
stock quote shares RVTY – Revvity Inc Stock Price stock today
news today RVTY – Revvity Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch RVTY – Revvity Inc yahoo finance google finance
stock history RVTY – Revvity Inc invest stock market
stock prices RVTY premarket after hours
ticker RVTY fair value insiders trading